Paul Knight
Stock Analyst at Keybanc
(1.85)
# 3,266
Out of 5,149 analysts
139
Total ratings
45.22%
Success rate
-2.54%
Average return
Main Sectors:
Stocks Rated by Paul Knight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMO Thermo Fisher Scientific | Upgrades: Overweight | $750 | $508.58 | +47.47% | 7 | Dec 8, 2025 | |
| WST West Pharmaceutical Services | Maintains: Overweight | $325 → $350 | $251.25 | +39.30% | 12 | Oct 24, 2025 | |
| XGN Exagen | Maintains: Overweight | $12 → $15 | $3.55 | +322.54% | 7 | Oct 14, 2025 | |
| LFCR Lifecore Biomedical | Initiates: Sector Weight | n/a | $7.23 | - | 1 | Sep 4, 2025 | |
| ATR AptarGroup | Initiates: Overweight | $220 | $142.67 | +54.20% | 1 | Sep 4, 2025 | |
| CYRX Cryoport | Upgrades: Overweight | $15 | $8.21 | +82.70% | 9 | Aug 6, 2025 | |
| HBIO Harvard Bioscience | Downgrades: Sector Weight | n/a | $0.59 | - | 5 | Apr 9, 2025 | |
| TECH Bio-Techne | Downgrades: Sector Weight | n/a | $57.82 | - | 9 | Apr 9, 2025 | |
| WAT Waters | Upgrades: Overweight | $460 | $307.23 | +49.72% | 5 | Mar 31, 2025 | |
| LAB Standard BioTools | Downgrades: Sector Weight | n/a | $1.10 | - | 2 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $8 | $4.40 | +81.82% | 1 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $132 → $145 | $95.59 | +51.69% | 3 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $420 | $176.17 | +138.41% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $213 → $230 | $114.51 | +100.86% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $33 | $22.52 | +46.54% | 5 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $36 | $27.99 | +28.62% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $310 | $206.00 | +50.49% | 9 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $210 → $220 | $124.97 | +76.04% | 7 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $35 → $37 | $15.09 | +145.20% | 5 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $3.61 | - | 8 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $2.38 | - | 1 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $118.17 | - | 8 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $25.84 | - | 3 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $51 → $40 | $8.81 | +354.03% | 6 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $390 → $300 | $178.61 | +67.96% | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $250 | $174.27 | +43.46% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $382 → $441 | $122.93 | +258.74% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $222 → $236 | $146.99 | +60.56% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $92 → $99 | $83.92 | +17.97% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $47 → $55 | $13.98 | +293.42% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $36.01 | - | 4 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $93.53 | - | 1 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $132.89 | - | 5 | Oct 23, 2017 |
Thermo Fisher Scientific
Dec 8, 2025
Upgrades: Overweight
Price Target: $750
Current: $508.58
Upside: +47.47%
West Pharmaceutical Services
Oct 24, 2025
Maintains: Overweight
Price Target: $325 → $350
Current: $251.25
Upside: +39.30%
Exagen
Oct 14, 2025
Maintains: Overweight
Price Target: $12 → $15
Current: $3.55
Upside: +322.54%
Lifecore Biomedical
Sep 4, 2025
Initiates: Sector Weight
Price Target: n/a
Current: $7.23
Upside: -
AptarGroup
Sep 4, 2025
Initiates: Overweight
Price Target: $220
Current: $142.67
Upside: +54.20%
Cryoport
Aug 6, 2025
Upgrades: Overweight
Price Target: $15
Current: $8.21
Upside: +82.70%
Harvard Bioscience
Apr 9, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $0.59
Upside: -
Bio-Techne
Apr 9, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $57.82
Upside: -
Waters
Mar 31, 2025
Upgrades: Overweight
Price Target: $460
Current: $307.23
Upside: +49.72%
Standard BioTools
Feb 27, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $1.10
Upside: -
Feb 12, 2025
Initiates: Overweight
Price Target: $8
Current: $4.40
Upside: +81.82%
Feb 3, 2025
Maintains: Overweight
Price Target: $132 → $145
Current: $95.59
Upside: +51.69%
Jan 23, 2025
Maintains: Overweight
Price Target: $400 → $420
Current: $176.17
Upside: +138.41%
Jan 23, 2025
Maintains: Overweight
Price Target: $213 → $230
Current: $114.51
Upside: +100.86%
Dec 13, 2024
Maintains: Overweight
Price Target: $30 → $33
Current: $22.52
Upside: +46.54%
Nov 5, 2024
Maintains: Overweight
Price Target: $28 → $36
Current: $27.99
Upside: +28.62%
Oct 23, 2024
Maintains: Overweight
Price Target: $290 → $310
Current: $206.00
Upside: +50.49%
Feb 15, 2024
Maintains: Overweight
Price Target: $210 → $220
Current: $124.97
Upside: +76.04%
Aug 30, 2023
Maintains: Overweight
Price Target: $35 → $37
Current: $15.09
Upside: +145.20%
Aug 8, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $3.61
Upside: -
Jul 12, 2023
Initiates: Sector Weight
Price Target: n/a
Current: $2.38
Upside: -
May 24, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $118.17
Upside: -
May 10, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $25.84
Upside: -
Sep 15, 2022
Maintains: Overweight
Price Target: $51 → $40
Current: $8.81
Upside: +354.03%
May 5, 2022
Maintains: Overweight
Price Target: $390 → $300
Current: $178.61
Upside: +67.96%
Apr 28, 2022
Maintains: Overweight
Price Target: $290 → $250
Current: $174.27
Upside: +43.46%
Jan 8, 2021
Maintains: Overweight
Price Target: $382 → $441
Current: $122.93
Upside: +258.74%
Jan 8, 2021
Maintains: Overweight
Price Target: $222 → $236
Current: $146.99
Upside: +60.56%
Jan 8, 2021
Maintains: Overweight
Price Target: $92 → $99
Current: $83.92
Upside: +17.97%
Jan 8, 2021
Maintains: Overweight
Price Target: $47 → $55
Current: $13.98
Upside: +293.42%
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $36.01
Upside: -
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $93.53
Upside: -
Oct 23, 2017
Upgrades: Neutral
Price Target: n/a
Current: $132.89
Upside: -